India Made Covishield Vaccine Gets ‘Green Pass’ in Switzerland, 7 Other EU Nations

Amidst multiple setbacks from European drug regulators, Covishield vaccine, in a significant boost, has been accepted by Switzerland drug regulator along with seven other European countries. According to sources quoted by news agency ANI, apart from Switzerland, the other countries which have approved Covishield include Austria, Germany, Slovenia, Greece, Iceland, Ireland, and Spain among others. Beneficiaries who have been administered by the Covishield vaccine will now be eligible to seek a green pass to visit these countries, top diplomatic sources involved in the process told news agency ANI.

The diplomatic sources said that the countries have accepted low-cost vaccine Covishield and agreed to include people administered with the vaccine on the list of eligible travellers.

With Covid-19 vaccination drive progressing at a steady pace in several countries, countries are opening up their borders for individuals who have been vaccinated by clinically certified Coronavirus vaccines.

In another positive signal for Covishield beneficiaries, the German embassy in a crucial statement hinted at granting approval to Covishield vaccine. The embassy said that versions of the EU-approved vaccines including licensed or original production are equivalent to already approved vaccines for proof of vaccine protection.

In a major setback to crores of beneficiaries of Covishield vaccine and manufacturer Serum Institute of India, the European Union had not approved Covishield vaccine manufactured in India. The drug regulator of the European Union said that the Indian manufactured version of AstraZeneca and Oxford University’s Coronavirus vaccine might have developed differences from the original vaccine due to change in the manufacturing condition in different settings.

The EU drug regulator has only approved four Coronavirus vaccines namely- Pfizer/BioNTech, Moderna, AstraZeneca and Johnson & Johnson. However, the EU drug regulator had said that individual countries of the European Union are free to take a call on issuing green passes to travellers vaccinated with Covishield vaccine.

(The article is posted from Financial Express without any modification.)

कोविशील्ड डोज के अंतराल को बढ़ाने से कोई हानि नहीं होगी – डॉ. वी. के. पॉल, नीति आयोग

कोविशील्ड डोज के अंतराल को बढ़ाने से कोई हानि नहीं होगी, इसे बढ़ाने का फैसला WHO द्वारा अनुमति के बाद ही लिया गया है। – डॉ. वी. के पॉल, नीति आयोग

India made COVISHIELD vaccine to be delivered to Myanmar, Mauritius, Seychelles

A consignment of 50,000 doses of COVISHIELD vaccine is scheduled to reach Seychelles as part of India’s vaccine donation program. Seychelles is only among the four Indian Ocean countries to receive the Covishield vaccine, manufactured by the Serum Institute of India, as New Delhi grants assistance.

The donation of the vaccines under the VaccineMaitri demonstrates India’s role as a reliable partner of Seychelles and net security provider in the Indian Ocean Region. This is also reflective of India’s special relations with Seychelles and the central place enjoyed by Seychelles in Prime Minister Modi’s vision of SAGAR: “Security and Growth for All in the Region”.

Seychelles has around one lakh inhabitants and the 50 thousand doses will thus be able to cover nearly 25 percent of the total Seychelles population. A consignment of one lakh doses of COVISHIELD vaccine is slated to arrive in Mauritius on Friday. Mauritius also lies at the heart of India’s vision of ‘SAGAR – Security and Growth for All in the Region’.Mauritius has a population of less than 1.3 million inhabitants.

The donation of one lakh doses of Covishield vaccines to Mauritius will cover vaccination requirement of a considerable percentage of its frontline medical workers and will play a vital role in complementing its ongoing recovery plans from the effects of the pandemic.A consignment containing 1.5 million doses of COVISHEILD vaccines from India will reach Yangon on Friday.

Sources said Myanmar is one of the first countries to receive Indian government’s gift of the “Make in India” COVIDSHIELD vaccines, manufactured by the Serum Institute of India. Myanmar is an important land and maritime neighbour of India with which India shares close historical, civilisational, cultural, religious, linguistic and ethnic ties. Myanmar is a vital component of India’s “Neighbourhood First” and “Act East” policies.

Brazil requested two million doses of Covishield vaccine from India on priority basis

Brazilian President Jair Bolsonaro has requested India for 2 million doses of Covishield vaccine produced indigenously by the Serum Institute of India, Pune. Mr Bolsonaro has written a letter to Prime Minister Narendra Modi to expedite the shipment of Covishield vaccine to Brazil without affecting India’s vaccination program.

Mr Bolsonaro’s letter, released by his press office, comes amid growing pressure to speed up Brazil’s vaccine rollout and end the world’s second-deadliest coronavirus outbreak. Brazilian National Immunization Program has finalized the Covishield and Covaxin for emergency use in the country. Earlier, the federally funded Fiocruz biomedical center had requested an emergency use authorization for Covishield vaccine coming from India.